PAI
BIVV

Palo Alto Investors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Palo Alto Investors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-264,400
Closed -$14.3M – 37
2017
Q4 		$14.3M Buy
264,400
+53,100
+25% +$2.91M 0.61% 26
2017
Q3 		$12.1M Buy
+211,300
New +$12.4M 0.51% 25

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Palo Alto Investors's BIVV Position: Q1 2018 in Review

Palo Alto Investors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 264,400 shares — an estimated $14.3M sold.

Palo Alto Investors first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $14.3M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Palo Alto Investors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Palo Alto Investors sold 264,400 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $14.3M.
  • Palo Alto Investors first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Palo Alto Investors's Bioverativ Inc. Common Stock position peaked at $14.3M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Palo Alto Investors's 13F filing for Q1 2018, filed 15 May 2018.